Table 3.

Echocardiography change from baseline

	Control	Exercise	PhAm	ExPhAm
EDV (ul)	−13.34 ± 5.75	−13.62 ± 10.52	−10.52 ± 14.4	−6.37 ± 8.22
ESV (ul)	−23.7 ± 4.86	−17.43 ± 11.47	−28.93 ± 18.25	−1.96 ± 15.57 a b
SV (ul)	−4.36 ± 13.53	−10.11 ± 11.89	3.3 ± 10.96	−9.55 ± 7.89
FS (%)	21.83 ± 21.37	13.05 ± 29.33	23.87 ± 16.99	−4.23 ± 34.35
CO (ml/min)	−1.06 ± 17.82	−11.98 ± 7.65	2.22 ± 13.01	−7.1 ± 6.63
GLS (%)	−1.85 ± 24.15	−6.38 ± 21.17	9.62 ± 7.28	−10.72 ± 18.03
EF (%)	9.83 ± 9.29	3.84 ± 5.93	16.9 ± 11.46	−2.91 ± 7.15 c
EDLVM	20.28 ± 25.49	−29.21 ± 14.61 d e	0.89 ± 13.59	−9.67 ± 10.83 f
ESLVM	12.87 ± 14.81	−31.81 ± 14.16 g h	−2.7 ± 13.59	−16.69 ± 9.27 g
Heart Rate (bpm)	3.39 ± 10.82	−1.08 ± 7.65	−1.06 ± 9.16	2.56 ± 5.50
LV Mass (mg)	15.01 ± 4.92	10.72 ± 15.21	15.24 ± 18.71	8.74 ± 13.34
LV/BM Index (%)	−10.33 ± 11.47	4.49 ± 11.04	−4.18 ± 19.05	1.14 ± 15.24

Data are mean ± standard deviatoin and were compared with a one-way ANOVA. PhAm, phellodendrun amurense; ExPhAm, exercise with phellodendrun amurense;

^ap=0.055 compared to control,

^bp=0.014 compared to PhAm,

^cp=0.005 compared to PhAm;

^dp=0.04 compared to PhAm;

^ep<0.001 compared to control

^fp=0.033 compared to control

^gp<0.01 compared to control

^hp=0.008 compalred to PhAm